Braskem S.A.
NYSE:BAK · New York Stock Exchange
-$0.40 today
Vol 5.04M · Avg 2.97M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
60.0%
avg 182.6%
ROIC
-6.2%
avg -3.8%
ROA
-11.8%
avg -4.7%
Analysis
ROE is currently the strongest return metric at 60.0% versus its period average of 182.6%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Nir Lander | Vice President of People, Communication & Supply Chain | — | — | — | $23,725.00 | <0.01% |
Daniel MacEachran | Head of Metabolic Engineering | — | — | — | $0.00 | <0.01% |
Felipe Montoro Jens | Chief Financial & Investor Relations Officer | — | — | 55 | $47,458.00 | 0.01% |
Geraldo Magela de Moraes Vilaca Netto | Executive Officer and Head of Legal, Corporate Governance & Intellectual Property | — | — | 46 | $0.00 | <0.01% |
João Henrique Rittershaussen | Executive Officer and Head of Investments & Digital Technologies | — | — | 62 | — | — |
Roberto Prisco Paraíso Ramos | Chief Executive Officer | — | — | 80 | $0.00 | <0.01% |
Stefan Lanna Lepecki | Executive Officer & Head of South America Business | — | — | 64 | $62,640.00 | 0.02% |
Rosana Avolio | Investor Relations Manager | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | -16.4% (15yr)1 analysts |
| Revenue | N/A | N/A | +10.0% | +2.5% (15yr)3 analysts |
| Net Income | N/A | N/A | N/A | -16.6% (15yr)3 analysts |
| EBIT | N/A | N/A | +66.1% | -8.5% (15yr)3 analysts |
Analysis
Recent growth has been strongest in EBIT at +66.1% over three years. Forward estimates point to Revenue at +2.5% (15yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
REX American Resources Corporation
NYSE:REX
$1.42B
Ecovyst Inc.
NYSE:ECVT
$1.38B
Collective Mining Ltd.
AMEX:CNL
$1.30B
Stepan Company
NYSE:SCL
$1.24B
Northern Dynasty Minerals Ltd.
AMEX:NAK
$1.18B
CVR Partners, LP
NYSE:UAN
$1.17B
McEwen Mining Inc.
NYSE:MUX
$1.16B
Westlake Chemical Partners LP
NYSE:WLKP
$798.32M
Rayonier Advanced Materials Inc.
NYSE:RYAM
$608.30M
ASP Isotopes Inc. Common Stock
NASDAQ:ASPI
$593.73M
Who manages BAK?
Braskem S.A. (BAK) lists 8 active executives. The top listed executive is Nir Lander, Vice President of People, Communication & Supply Chain.
Are BAK insiders buying or selling?
Recent insider activity shows net buying of $0.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.